HC Wainwright Brokers Decrease Earnings Estimates for RARE
Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE - Free Report) - Research analysts at HC Wainwright dropped their Q1 2027 earnings estimates for shares of Ultragenyx Pharmaceutical in a research report issued on Monday, May 11th. HC Wainwright analyst R. Selvaraju now anticipates that the biopharmaceuti
Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE - Free Report) - Research analysts at HC Wainwright dropped their Q1 2027 earnings estimates for shares of Ultragenyx Pharmaceutical in a research report issued on Monday, May 11th. HC Wainwright analyst R. Selvaraju now anticipates that the biopharmaceuti
What's Your Reaction?
:max_bytes(150000):strip_icc()/GettyImages-2187410260-5afe56694791404f99c253dd8d5abe6a.jpg?#)
